Literature DB >> 32552561

Social Media Use for Inflammatory Bowel Disease in a Rural Appalachian Population.

Tarika Sejal Chowdhary1, Jesse Thompson1, Swapna Gayam2.   

Abstract

Background: Social media use is prevalent in our society and has become widely used in the health care community. Inflammatory bowel disease (IBD) patients constitute one of the patient populations that benefit from social media use to obtain information on their diseases. West Virginia (WV) is a rural Appalachian state with barriers to internet access and health care and we examined the role that social media plays in patients' lives in this state, which could be reflective of other rural states.
Methods: Our patient population consisted of patients, 18-65 years old, who live in WV with a diagnosis of IBD. A 17-question survey was sent to 2,131 patients over a course of 4 weeks through an application called REDCap.
Results: We received 624 responses with a 29% response rate. Approximately 30% of patients reported that they used Facebook for IBD-related information, while 4.3% used Instagram. While most (92%) patients preferred information coming from their physician, the majority judged information from the internet to be reliable (39.3%) or neutral (44.9%). Most patients believed that social media had no impact on their disease management (67%), while 30.3% believed it had a positive impact. Almost 45% of patients stated that they wished their physician had a social media account for IBD. Conclusions: Our study shows that patients are interested in obtaining health-related information from social media resources. As physicians, it is our job to point them in the right direction to be able to find reliable information.

Entities:  

Keywords:  IBD; rural population; social media; telemedicine

Mesh:

Year:  2020        PMID: 32552561      PMCID: PMC8195876          DOI: 10.1089/tmj.2020.0014

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  8 in total

1.  Individual differences in false memory from misinformation: cognitive factors.

Authors:  Bi Zhu; Chuansheng Chen; Elizabeth F Loftus; Chongde Lin; Qinghua He; Chunhui Chen; He Li; Gui Xue; Zhonglin Lu; Qi Dong
Journal:  Memory       Date:  2010-07

2.  Social media use in patients with inflammatory bowel disease and chronic viral hepatitis.

Authors:  C Timms; D M Forton; A Poullis
Journal:  Clin Med (Lond)       Date:  2014-04       Impact factor: 2.659

3.  Harnessing the Hashtag: A Standard Approach to GI Dialogue on Social Media.

Authors:  Austin L Chiang; Bryan Vartabedian; Brennan Spiegel
Journal:  Am J Gastroenterol       Date:  2016-06-28       Impact factor: 10.864

Review 4.  Social Media Use in Patients with Inflammatory Bowel Disease.

Authors:  Ling Guo; Jason Reich; Jacob Groshek; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

5.  Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease: Insights from a Large-scale Analysis of Social Media Platforms.

Authors:  Bibiana Martinez; Francis Dailey; Christopher V Almario; Michelle S Keller; Mansee Desai; Taylor Dupuy; Sasan Mosadeghi; Cynthia Whitman; Karen Lasch; Lyann Ursos; Brennan M R Spiegel
Journal:  Inflamm Bowel Dis       Date:  2017-07       Impact factor: 5.325

6.  A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease.

Authors:  Jason Reich; Ling Guo; Julia Hall; Ashley Tran; Janice Weinberg; Jacob Groshek; Tanya E Rowell; Jack A DiPalma; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

7.  Social Media Use and Preferences in Patients With Inflammatory Bowel Disease.

Authors:  Jason Reich; Ling Guo; Jacob Groshek; Janice Weinberg; Wenli Chen; Christopher Martin; Millie D Long; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2019-02-21       Impact factor: 5.325

8.  Internet and social media for health-related information and communication in health care: preferences of the Dutch general population.

Authors:  Tom H Van de Belt; Lucien J L P G Engelen; Sivera A A Berben; Steven Teerenstra; Melvin Samsom; Lisette Schoonhoven
Journal:  J Med Internet Res       Date:  2013-10-02       Impact factor: 5.428

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.